Lv41
590 积分 2023-09-10 加入
Immunological dynamics in MASH: from landscape analysis to therapeutic intervention
3小时前
已完结
Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)
7天前
已完结
Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
1个月前
已完结
皖公网安备34019202002308
